In fact they reported a reduction in distant tumor (lung carcinoma or fibrosarcoma implanted in the dorsal midline) after high dose RT delivered to the leg of immunocompetent mice, while an AE antitumor response was not observed in p53 knockout mice or in mice with p53 pharmacologically inhibited [20]. The gene discussed is TP53; the disease is lung carcinoma.